Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Breast Cancer (Tokyo, Japan)|July 12, 2019
Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriersNaomi Nagura, Naoki Hayashi, Junko Takei, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 27, 2021
Epitope Mapping of an Anti-Human CCR9 Monoclonal Antibody (C9Mab-1) Using Enzyme-Linked Immunosorbent AssayJunko Takei, Teizo Asano, Guanjie Li, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|November 14, 2019
PMab-241 Specifically Detects Bear Podoplanin of Lymphatic Endothelial Cells in the Lung of Brown BearJunko Takei, Shinji Yamada, Satoru Konnai, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|May 27, 2021
Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow CytometryHideki Hosono, Teizo Asano, Junko Takei, et al.
Biochemistry and Biophysics Reports|January 25, 2021
Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysisYusuke Sayama, Mika K Kaneko, Junko Takei, et al.
Biochemistry and Biophysics Reports|April 19, 2019
Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analysesYukinari Kato, Yoshikazu Furusawa, Shinji Yamada, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 27, 2021
Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) Using Enzyme-Linked Immunosorbent AssayJunko Takei, Hiroyuki Suzuki, Teizo Asano, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 27, 2021
Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) Using the HisMAP MethodTeizo Asano, Junko Takei, Yoshikazu Furusawa, et al.
Breast Cancer Research and Treatment|May 14, 2026
Impact of BRCA1/2 pathogenic variants on ipsilateral breast tumor recurrence and prognosis following breast-conserving surgerySakiko Kondo, Kumiko Kida, Misato Suzuki, et al.
Clinical Breast Cancer|October 13, 2020
Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2- Breast Cancer: A Prospective Phase II StudyNaoki Hayashi, Hiroshi Yagata, Koichiro Tsugawa, et al.
Pageof 10